Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Caffeine recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Caffeine (51 total). Check the affected lots below.

Most common reason: cGMP deviation (22 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Caffeine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Caffeine recalls on record

none so far in 2026; 51 on record, newest first
Class II · Moderate risk

Acetaminophen 500mg Caffeine 65mg caplets

Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.

Ongoing Labeling / mix-up Aero Healthcare NDC 55305-135-01 D-0155-2026
Class I · High risk

Healthy Living Acetaminophen

Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

Ongoing Labeling / mix-up Aurobindo Pharma USA Inc NDC 58602-882-21 D-0641-2024
Class II · Moderate risk

Migrenol Caplet

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62959-565-00 D-0547-2022
Class II · Moderate risk

HPC Tablet

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62969-242-00 D-0538-2022
Class II · Moderate risk

Painaid

cGMP deviations

Terminated cGMP deviation Ultra Seal Corporation D-0492-2022
Class II · Moderate risk

Back Pain-Off

cGMP deviations

Terminated cGMP deviation Ultra Seal Corporation NDC 47682-073-00 D-0476-2022
Class II · Moderate risk

Extra Strength Headache

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0391-2022
Class II · Moderate risk

Medique Pain-Off

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0390-2022
Class II · Moderate risk

Physicians CARE Extra Strength PAIN RELIEVER

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0389-2022
Class II · Moderate risk

Pain Aid Esf-

CGMP Deviations: failed stability results, inadequate laboratory investigations,

Terminated Stability / shelf life ULTRAtab Laboratories, Inc. NDC 62959-560-00 D-0327-2022